225 related articles for article (PubMed ID: 15919766)
41. Regulation of drug transporter gene expression by nuclear receptors.
Staudinger JL; Madan A; Carol KM; Parkinson A
Drug Metab Dispos; 2003 May; 31(5):523-7. PubMed ID: 12695338
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.
Li T; Chiang JY
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G74-84. PubMed ID: 15331348
[TBL] [Abstract][Full Text] [Related]
43. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands.
Toell A; Kröncke KD; Kleinert H; Carlberg C
J Cell Biochem; 2002; 85(1):72-82. PubMed ID: 11891851
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR.
Tamasi V; Juvan P; Beer M; Rozman D; Meyer UA
Mol Pharm; 2009; 6(5):1573-81. PubMed ID: 19708687
[TBL] [Abstract][Full Text] [Related]
45. Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression.
Shi Z; Yang W; Goldstein JA; Zhang SY
Biochem Pharmacol; 2014 Aug; 90(4):425-31. PubMed ID: 24960263
[TBL] [Abstract][Full Text] [Related]
46. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways.
Li L; Stanton JD; Tolson AH; Luo Y; Wang H
Pharm Res; 2009 Apr; 26(4):872-82. PubMed ID: 19034627
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4alpha interaction.
Lim YP; Kuo SC; Lai ML; Huang JD
Pharmacogenet Genomics; 2009 Jan; 19(1):11-24. PubMed ID: 19077665
[TBL] [Abstract][Full Text] [Related]
48. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity.
Zhang J; Huang W; Qatanani M; Evans RM; Moore DD
J Biol Chem; 2004 Nov; 279(47):49517-22. PubMed ID: 15358766
[TBL] [Abstract][Full Text] [Related]
49. A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.
Chen L; Bao Y; Piekos SC; Zhu K; Zhang L; Zhong XB
Mol Pharmacol; 2018 Jul; 94(1):749-759. PubMed ID: 29691280
[TBL] [Abstract][Full Text] [Related]
50. Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4alpha in large-for-gestational-age neonatal rats.
Ni S; Wang X; Wang J; Zeng S; Zhao Z
Pharmazie; 2009 Apr; 64(4):252-7. PubMed ID: 19435144
[TBL] [Abstract][Full Text] [Related]
51. Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.
Ulvila J; Arpiainen S; Pelkonen O; Aida K; Sueyoshi T; Negishi M; Hakkola J
Biochem J; 2004 Aug; 381(Pt 3):887-94. PubMed ID: 15115437
[TBL] [Abstract][Full Text] [Related]
52. In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors.
Zhang W; Purchio A; Chen K; Burns SM; Contag CH; Contag PR
Biochem Pharmacol; 2003 Jun; 65(11):1889-96. PubMed ID: 12781341
[TBL] [Abstract][Full Text] [Related]
53. Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors.
Huss JM; Kasper CB
Mol Pharmacol; 2000 Jul; 58(1):48-57. PubMed ID: 10860926
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.
Martin P; Riley R; Back DJ; Owen A
Br J Pharmacol; 2008 Feb; 153(4):805-19. PubMed ID: 18037906
[TBL] [Abstract][Full Text] [Related]
55. Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes.
Roth A; Looser R; Kaufmann M; Meyer UA
Pharmacogenet Genomics; 2008 Apr; 18(4):325-37. PubMed ID: 18334917
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions.
Ibeanu GC; Goldstein JA
Biochemistry; 1995 Jun; 34(25):8028-36. PubMed ID: 7794915
[TBL] [Abstract][Full Text] [Related]
57. Drug-activated nuclear receptors CAR and PXR.
Honkakoski P; Sueyoshi T; Negishi M
Ann Med; 2003; 35(3):172-82. PubMed ID: 12822739
[TBL] [Abstract][Full Text] [Related]
58. Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor.
Kohalmy K; Tamási V; Kóbori L; Sárváry E; Pascussi JM; Porrogi P; Rozman D; Prough RA; Meyer UA; Monostory K
Drug Metab Dispos; 2007 Sep; 35(9):1495-501. PubMed ID: 17591676
[TBL] [Abstract][Full Text] [Related]
59. Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation.
Kittayaruksakul S; Zhao W; Xu M; Ren S; Lu J; Wang J; Downes M; Evans RM; Venkataramanan R; Chatsudthipong V; Xie W
Pharm Res; 2013 Sep; 30(9):2199-208. PubMed ID: 23896737
[TBL] [Abstract][Full Text] [Related]
60. Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor.
Hoffart E; Ghebreghiorghis L; Nussler AK; Thasler WE; Weiss TS; Schwab M; Burk O
Br J Pharmacol; 2012 Mar; 165(5):1595-608. PubMed ID: 21913896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
